Publication | Open Access

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial

Rheumatoid DisorderRheumatologyLow Disease ActivityAutoimmune DiseaseRheumatic DiseasesChronic Musculoskeletal ConditionClinical TrialsInflammatory Rheumatic DiseaseRehabilitationMedicineRheumatoid Arthritis